Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Cigna ( (CI) ) is now available.
The Cigna Group, a prominent player in the healthcare industry, has reaffirmed its projected full-year 2025 consolidated adjusted income from operations, expecting at least $29.60 per share. This announcement, initially discussed in July 2025, underscores Cigna’s confidence in its financial performance and strategic positioning despite the inherent uncertainties and risks in the evolving healthcare sector.
The most recent analyst rating on (CI) stock is a Buy with a $335.00 price target. To see the full list of analyst forecasts on Cigna stock, see the CI Stock Forecast page.
Spark’s Take on CI Stock
According to Spark, TipRanks’ AI Analyst, CI is a Outperform.
Cigna’s overall stock score reflects strong financial performance and strategic growth initiatives, particularly in Evernorth. However, cash flow challenges and elevated medical costs present risks. Technical analysis indicates mixed signals, and the valuation is fair but not particularly compelling.
To see Spark’s full report on CI stock, click here.
More about Cigna
Average Trading Volume: 1,876,682
Technical Sentiment Signal: Hold
Current Market Cap: $80.31B
For detailed information about CI stock, go to TipRanks’ Stock Analysis page.